Target intelligence / Profile preview

Beta-lactamase Class C (AmpC)

Target
AmpC
Molecular classification
Enzyme, Hydrolase, Serine hydrolase
01

Overview

Class C β-lactamases, also known as AmpC β-lactamases or cephalosporinases, are enzymes produced by many Gram-negative bacteria that confer resistance to a broad range of β-lactam antibiotics. These enzymes hydrolyze the amide bond in the β-lactam ring of antibiotics, rendering them ineffective. They are serine hydrolases, utilizing a serine residue to attack and hydrolyze the β-lactam ring. AmpC beta-lactamases are not inhibited by classic inhibitors such as clavulanic acid, sulbactam, or tazobactam; some newer inhibitors like avibactam can inhibit AmpC enzymes. These enzymes are a major cause of resistance to extended-spectrum cephalosporins in clinical isolates.

Other names
AmpC beta-lactamaseCephalosporinase
02

Mechanism of action

Hydrolyzes the beta-lactam ring of antibiotics, rendering them inactive.

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam antibiotics
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Contributes to antibiotic resistance, leading to treatment failures.Poor inhibition by traditional beta-lactamase inhibitors necessitates use of alternative antibiotics or newer inhibitor combinations.
06

Interacting drugs

Penicillins

6 more in the full profile.

Beyond the preview

Go deeper on Beta-lactamase Class C (AmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase Class C (AmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call